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METHODOLOGY Open Access
The OMACS-PIL study: a randomised
controlled trial within the OMACS
observational study
Lucy Culliford* , Rachel Brierley, Madeleine Clout, Rebecca Evans, Rachel Maishman, Dawn Phillips, Hana Tabusa,
Barney Reeves and Chris A. Rogers
Abstract
Background: There has been little research to investigate whether the appearance of paper patient information
leaflets (PILs) used to describe research studies to potential participants influences their decision to take part.
Embedding a study within a trial (SWAT) is an efficient way of answering this type of methodological question. We
included a randomised SWAT within a large cohort study, Outcome Monitoring after Cardiac Surgery (OMACS), to
address this question.
Methods: Potential participants for the OMACS study were randomised to receive one of three PILs, which were
identical in content but with varying formatting and use of colour: PIL A (enhanced format), PIL B (hybrid format)
and PIL C (standard format). Consent to OMACS was the primary outcome. Consent rates using the three different
PIL formats were collected and compared. Qualitative feedback on the different formats was obtained from a public
and patient involvement (PPI) group.
Results: For the SWAT, 1517 PILs were sent to potential participants, of whom 640 (42%) consented to take part in
OMACS. PIL B had the highest recruitment rate, with 45% of patients consenting to participation; 40% and 41% of
patients consented to participation after receiving PILs A and C, respectively. Compared to PIL C, the consent rate
was 4% higher with PIL B (45% versus 41%, 95% confidence interval (CI) -2% to + 10%, p = 0.16) and 1% lower with
PIL A (40% versus 41%, 95% CI − 7% to + 5%, p = 0.72).
Conclusions: Consent rates were similar for all three PIL formats. PIL B is being used for the remainder of the host
study and will be used to inform the design of PILs for other research studies, as it was the preferred format of the
PPI group.
Trial registration: International Clinical Trials Registry, ISRCTN90204321. Registered on 21 January 2015.
Keywords: Patient information leaflet, randomised, study within a study, recruitment, consent
Background
Much research has been conducted on how to improve
patient information leaflets (PILs), the consent process,
recruitment in randomised controlled trials (RCTs) and
response rates to postal questionnaires, which is sum-
marised in several reviews [1–6]. The main focus of that
research with respect to PILs has been on the readability
or length of PILs [7–15] and use of different media such
as audio-visual materials [5] or interactive electronic ma-
terials [16], rather than how the appearance of paper
PILs can be improved. The outcomes have been patients’
understanding of the study or their satisfaction with the
informed consent procedure. There has been less focus
on whether recruitment rates can be improved, leading
to a lack of evidence in this area. The conclusion of a
Cochrane review [4] was that there is currently no clear
evidence as to whether modifications to the information
presented to participants improves recruitment to RCTs.
This conclusion is consistent with that of previous re-
views that reported that more research is required [1, 2].
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In addition, the design and delivery of information used
to invite potential participants into a study has also been
identified as a research priority by the Prioritising
Recruitment in Randomised Trials study (PRioRiTy) to
improve how people are recruited to clinical trials [17].
With respect to the format of the PIL, Reinert and col-
leagues [11] performed a quantitative and qualitative
analysis of study PILs and concluded that information
presented to potential participants “needs to be well
structured and designed in an appealing manner”. That
study focused on how the appearance of a paper PIL
might affect the decision to take part in a study, rather
than the content. However, efforts were still made to
make sure the content was readable and the length of
the PIL kept to a minimum. The current research was
conducted as a study within a trial (SWAT) by nesting it
within a large cohort study, Outcome Monitoring after
Cardiac Surgery (OMACS). The objective of the SWAT,
OMACS-PIL, was to compare rates of consent using dif-
ferent formats of the host study PIL. Conducting a
SWAT is an efficient method of gathering evidence to
address uncertainties about the best way to conduct clin-
ical studies and allows methodological evidence to be
collected during the main study [18, 19]. In the context
of this study, we wanted to make sure that any updates
to our PIL were based on evidence. We hypothesised
that a PIL with an appealing appearance would be more
likely to be read, which would lead to an increased
recruitment rate.
Methods
The main study
The OMACS study is an ongoing cohort study. Cardiac
surgery patients at our institution (University Hospitals
Bristol NHS Foundation Trust) are asked to consent to
the collection and use of quality of life data, plus data
routinely collected about their operation and subsequent
recovery. The data collected can then be used in a range
of research studies. Patients are approached for consent
by post 3 months after their operation. The inclusion cri-
teria for OMACS are adult participants over the age of
18 years who have undergone cardiac surgery at our in-
stitution. Around 1000 patients per year are approached
to take part. The only patients not eligible to participate
are prisoners, patients without the mental capacity to
give consent and patients whose main residence is out-
side the United Kingdom. OMACS is ongoing and the
results of the SWAT will be applied to future recruit-
ment to OMACS. This study was chosen as it uses pos-
tal consent, so the appearance of the PIL may have more
impact than for face-to-face consent, plus the large tar-
get population meant that the SWAT could be com-
pleted quickly.
The SWAT
OMACS-PIL was an RCT to investigate whether recruit-
ment to the main OMACS study was affected by the
format of the information provided to potential partici-
pants. Three different information leaflets were pre-
pared, each with the same content but using different
styles and formatting. PIL A (enhanced format) and PIL
B (hybrid format) were produced with a specialised
graphics package called InDesign (Adobe Systems Incor-
porated) whereas PIL C (standard format) was produced
using Microsoft Word (Microsoft Corporation). PIL A
was a full colour tri-fold leaflet, PIL B was a double-
sided A4 sheet using columns to break the text up with
some coloured headings, and PIL C was a black and
white A4 double-sided sheet with standard formatting.
Examples of each format can be seen in Fig. 1.
Potential participants were randomly assigned to re-
ceive PIL A, B or C in the ratio 1:1:1. The randomisation
list was prepared by the study statistician using Stata
version 15.1 (StataCorp LP, College Station, TX) and
uploaded to the study database. The allocation was
linked to the participant record and printed onto the
footer of each mail-merged invite letter to allow the cor-
rect PIL to be attached. Invitation letters for the main
study are prepared for mailing as a monthly batch. To
avoid making mistakes in including the correct PIL, the
letters were printed in three separate batches, each
corresponding to a single PIL allocation. Potential par-
ticipants were unaware that they were taking part in
OMACS-PIL. Members of the study team were not
blinded but had no direct contact with potential partici-
pants and so were unable to influence consent rates.
Study population
The study population for OMACS-PIL comprised pa-
tients eligible for the OMACS study during the period of
the SWAT. With the approval of a National Health Ser-
vice (NHS) research ethics committee (14/EM/1222), pa-
tients were not informed of the SWAT, as knowledge of
the SWAT may have influenced how they viewed the
PIL. The recruitment period of the SWAT was from 1
June 2016 to 30 September 2017.
Outcome
The outcome measure was consent to OMACS in each
of the groups receiving PIL A, B or C.
Sample size
Assuming a consent rate of 70% with PIL C (based on
historic data from a similar cohort study that ran over
several years [20]), then a sample size of 1590 (530 per
group) would give 90% power to detect a 10% difference
in consent rate between any pair of PIL formats, with an
overall significance level of 5% (with a Bonferroni
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correction for the three comparisons). This was the
number of patients to be sent a PIL, rather than the
number of patients required to consent. We chose a 10%
difference as a compromise between: (a) the large in-
crease in returns of postal questionnaires seen with
some measures, such as those with coloured ink (odds
ratio 1.39, 95% confidence interval [CI] 1.16–1.67) as re-
ported in the Cochrane review of measures that can in-
crease responses to postal questionnaires [6] and (b) the
conclusion of the Cochrane review on increasing partici-
pation in clinical trials that there is currently no clear
evidence for whether modifications to the information
presented to participants improves recruitment to RCTs
[4].
Statistical analysis
The consent rates for the three different PIL formats were
described and the differences in consent rate between
pairs of PILs were modelled using a logistic regression in
Stata version 15.1 (StataCorp LP, College Station, TX).
Odds ratios with corresponding 95% CIs are presented for
the comparisons between PIL groups with PIL C as the
reference category. The analysis took place at the end of
the recruitment period for the SWAT.
Public and patient involvement
To get qualitative information about the PILs, they
were presented to the Cardiovascular Public and Pa-
tient Involvement (PPI) group of Bristol Biomedical
Research Unit, which comprises people who have had
cardiac surgery, to elicit their preferences for the for-
mat and appearance of the PILs and the reasons for
their preferences. The PPI group were not participat-
ing in OMACS as they had undergone cardiac surgery
before the study started. The group was formed after
the start of the SWAT and so did not contribute to
Fig. 1 Appearance of the PILs. a Tri-fold coloured leaflet produced using a graphic design package, InDesign, by professional printers (enhanced
PIL). b Coloured A4 sheet produced using a graphic design package, InDesign, by professional printers (hybrid PIL). c Black and white A4 sheet
produced in Microsoft Word (standard PIL). PIL patient information leaflet
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the design or content of the PILs, and their observa-
tions were obtained whilst the SWAT was taking
place. The PPI group had five members and the in-
formation was obtained by the PPI coordinator, who
was independent of the study. The OMACS chief in-
vestigator was present to explain the study.
Results
For the duration of the SWAT, 1517 invitation letters
and PILs were sent to eligible cardiac surgery patients.
The numbers of each format of PIL sent were: PIL A
505, PIL B 506 and PIL C 506. The age and sex of the
target population are listed in Table 1. The mean age
was 64.9 years (standard deviation 13.4), and 1079 /
1517 (71.1%) were male. The average age and propor-
tion of male patients was very similar across the three
groups.
In total, 640 patients (42%) consented to take part in
OMACS. Consent rates across the three PIL formats are
shown in Fig. 2. PIL B had the highest recruitment rate,
with 45% (95% CI 41–50%) of patients consenting to
participation whereas PIL A had the lowest recruitment
rate, with 40% (95% CI 35–45%) of patients consenting
to participation. The consent rate for PIL C was 41%
(95% CI 36–46%). Compared to PIL C (standard format),
the consent rate was 4% higher with PIL B (95% CI -2%
to + 10%, p = 0.16) and 1% lower with PIL A (95% CI
-7% to + 5%, p = 0.72).
When the different PIL formats were presented to
our Cardiovascular PPI group, their general prefer-
ence was for PIL B, and their least favourite was PIL
A. The PPI group felt very strongly that PIL A (en-
hanced format) looked too professional and looked
like advertising material, like leaflets that are posted
through letterboxes ‘advertising takeaways’. They also
did not like that the study logo took up most of the
front page of PIL A, since on receipt of the PIL they
would not know what OMACS was. By contrast, for
PILs B and C, they could quickly understand that
OMACS was a research study. Although the group
did not dislike PIL C (standard), on balance they felt
that the columnar presentation of PIL B made it
more ‘attractive’ and easier to read.
Discussion
OMACS-PIL has provided some evidence that the for-
matting of a PIL can influence the perception of a study
by potential participants, although the differences in
consent rates were not statistically significant. The re-
search team had hypothesised that PIL A would be most
appealing to read, as it looked the ‘most professional’,
but it was exactly this aspect that the PPI group did not
like. The consistency between the quantitative finding
and the PPI feedback reinforces the benefit of PPI being
an integral part of research.
The sample size achieved was just short of the 1590
target. This is because, due to the lower than expected
rates of consent across all PILs, the timing and mode of
consent were changed to seeking face-to-face consent at
the time of admission for the cardiac operation. The de-
cision to change to face-to-face consent coincided with
the sample size for the SWAT almost being met, and
the decision was made to halt OMACS-PIL at this point.
The modest increase in recruitment with PIL B is con-
sistent with other research on the design of consent mate-
rials. However, much of this previous research has
included other interventions alongside changes to the PIL.
For instance, in a RCT within the Avon Longitudinal
Study of Parents and Children Study, potential partici-
pants were randomised to receive one of eight combina-
tions of three interventions: (1) a prior-notification
postcard or no contact, (2) a standard or professionally de-
signed consent pack, and (3) a phone or postal reminder
[21]. Of these interventions, the most effective was the re-
minder phone call with a 6.4% higher response rate (95%
CI + 2.3 to + 10.6%; p = 0.002). The professionally de-
signed consent pack had some impact, increasing response
rates by 2.7% (95% CI − 0.06% to 5.5%; p = 0.06), but the
prior notification postcard had no effect. Phone call re-
minders can have significant resource implications, hence
our decision not to include this as an intervention.
The START programme run by the Medical Research
Council (MRC) also looked at the format of paper PILs,
but this was an enhanced PIL where the wording was
refined after several rounds of user testing [12, 13].
This approach has resource implications and of the
work published so far, there have been only marginal
improvements in recruitment [12, 15]. The Healthlines
studies showed modest increases in a positive response
to an invitation to participate in a study using the en-
hanced PIL, which, like OMACS-PIL, were not statisti-
cally significant (19% versus 16%, difference of 2.9%,
95% CI − 1.1% to 6.9% in the Healthlines depression
study, n = 1364, and 24.0% versus 21.9%, difference of
2.0%, 95% CI − 4.3% to 8.4% in the Healthlines cardio-
vascular disease study, n = 671) [12]. In Early CDT
Lung Cancer Scotland, the proportion of patients who
positively responded to the invitation was 224 / 1136
Table 1 Patient demography by PIL type
PIL n (%) Mean age in years
(standard deviation)
Males, n (%)
A 505 64.6 (13.5) 356 (70.5)
B 506 64.7 (14.2) 368 (72.7)
C 506 65.4 (12.5) 355 (70.2)
Overall 1517 64.9 (13.4) 1079 (71.1)
PIL patient information leaflet
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(19.7%) in the intervention group (optimised PIL) and
205 / 1126 (18.2%) in the control group (difference of
1.5%, 95% CI − 1.7% to 4.7%) [15]. In addition to these
MRC Start studies, the REFORM study concluded that
there was limited evidence of the benefit of using opti-
mised information materials on recruitment and reten-
tion rates [14] and the recently updated Cochrane
review of methods to enhance recruitment to RCTs
concluded that: ‘Using a tailored, user-testing approach
to develop participant information leaflets makes little
or no difference to recruitment’ [22]. There has been a
Cochrane review of methods to increase response rates
to postal questionnaires [6], but this focused on the
design of the questionnaire or the method of postage
(e.g. first-class post) and not on the PIL provided to
participants.
Resource implications for developing electronic media
and the limited existing evidence that these media can
improve recruitment [5] were the reasons that a multi-
media approach was not explored in OMACS-PIL.
One area for concern in OMACS is that the overall re-
sponse rate was much lower than expected. The expected
response rate was based on similar work involving postal
consent of cardiac surgery patients (Long-Term Monitor-
ing Study), which had been as high as 80% [20]. There are
a few differences between the studies: the timing of the
approach for consent was at 3months versus 12months
after cardiac surgery, and the packs sent to OMACS pa-
tients had more documents and offered more choices in
how to participate. The Long-Term Monitoring Study was
conducted purely by post, whereas OMACS allowed par-
ticipants to register, consent and complete questionnaires
online if they preferred. This extra complexity may have
contributed to the lower consent rate. The options were
offered to allow participants to complete the study in the
way most convenient to them, but it may be that the extra
thinking involved meant that they did not take part at all.
Again, this shows that researchers should not assume they
know what patients want.
A limitation of this study is that not all of the three PIL
formats would be suitable for all studies. The amount of
information that can be contained in the format of PIL A
is constrained. This was not a problem for OMACS as the
information required to be conveyed about OMACS was
limited, since OMACS is an observational study and not
an RCT, and therefore was easily incorporated into the
different formats. The format of PIL A may not be suitable
for interventional trials where more information about the
intervention and risk and benefits need to be included.
Even for OMACS, the volume of information included in
the PIL has increased since the SWAT was conducted,
due to the requirements of NHS Digital for hospital epi-
sode statistics, which is a feature of the main study. The
extra information was easily incorporated into PILs B and
C but would have been more challenging to incorporate
into PIL A due to the way that the information was pre-
sented and formatted. To make PIL B easier to use in
OMACS and other studies and to remove the need for
specialist software, we have now recreated the format in
Microsoft Word (Microsoft Corporation), and this format
is now being used for the host study.
The PPI work included was informal and the PPI
group was relatively small. However, their opinions were
consistent with the quantitative finding of the SWAT.
The PPI group were not involved in the design of the
PILs. However, the content of the PIL is under review
and their views will be considered for future versions.
We did not inform the potential participants about the
Fig. 2 Consent rates by PIL type. PIL patient information leaflet
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SWAT as we felt that it would influence how they
viewed the PIL, so we were unable to elicit potential par-
ticipant views about the PIL formats.
A strength of OMACS-PIL is that the formatting of the
PIL is something that can be improved in any study. A
positive improvement in recruitment rates does not require
rounds of user acceptability testing, as required by other
projects (e.g. MRC START), or extra resources, as required
with telephone contact or a multimedia approach, and
could be achieved with PPI input. This means that it can be
implemented with minimal or no impact on the study
budget. OMACS-PIL was randomised and the participants
were unaware of the SWAT. However, based on the results
of OMACS-PIL and the other similar studies, any improve-
ment in consent rates are likely to be small.
Conclusions
The hybrid PIL (PIL B) was preferred by the PPI group
and resulted in a slightly higher consent rate to the host
study than PIL A (enhanced format) or PIL C (standard
format), although this difference was not statistically sig-
nificant. PIL A, which was the most expensive to produce,
was the least preferred option for the PPI group and did
not improve consent rates. PIL B is now being used as the
PIL for the remainder of the OMACS study, and the find-
ings from this study are being used to inform the design
of PILs for interventional trials. The work also highlighted
the importance of involving PPI groups in the design of
information aimed at potential study participants.
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